Last updated on June 26th, 2020 at 12:28 pm
DNACPR procedures specific to patients with confirmed or suspected COVID19 must be reviewed here prior to patient discharge
When considering decisions and completing the uDNACPR Lilac form, patients can be acutely unwell and recovery could be uncertain.
This decision must be reviewed when clinical circumstances change and prior to the patient leaving the hospital (specifically when COVID-19 was a criterion for the decision).
Most uDNACPR decisions will remain in place appropriately, but some will warrant reversal. This could be the case for some patients with COVID19.
This uDNACPR review MUST be completed by the Senior Medical/Clinical Team caring for the patent and discussed with the patient and communicated to outside agencies upon discharge.